Fred joined Venrock in 2006 and is focused on the medical device and drug development sectors. At Venrock, Fred has led multiple investments, and presently serves on the Board of Directors of Receptos, Inc. Fred is also founder and CEO of ADVANCE Medical, a Venrock portfolio company that is focused on the commercialization of medical technology in Brazil and other countries in Latin America.
Prior to Venrock, he was with Atlas Venture assessing investments in medical devices and biotechnology. Earlier in his career, Fred was director of business development and head of investor relations for CuraGen Corporation, an oncology-focused drug development company. In this role, he was responsible for strategic planning, the in-licensing of a clinical stage oncology product, securing sell-side analyst coverage and helping raise over $100 million. Prior to CuraGen, he worked at Boston Consulting Group where he advised biotechnology and pharmaceutical companies.
Fred received his B.S. in Biology from Duke University, M.D. from Yale University School of Medicine and M.B.A. from the Harvard Business School.